NCT01548287 - A Study of the Safety and Tolerability of AZD5213 Effect on Sleep for Patients With Alzheimer's/Cognitive Impairment | Biotech Hunter

Enrollment

164

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Mild Cognitive ImpairmentMild Alzheimer's Disease

Interventions

DRUG

AZD5213

AZD5213 doseA daily

DRUG

AZD5213

AZD5213 doseB daily

DRUG

AZD5213

AZD5213 doseC daily

OTHER

Placebo

Placebo tablet daily

Trial Locations (13)

Research Site, Phoenix

Research Site, Indio

Research Site, Lomita

Research Site, San Francisco

Research Site, Delray Beach

Research Site, Fort Myers

Research Site, Hallandale

Research Site, Orlando

Research Site, Tampa

Research Site, Eatontown

Research Site, Brooklyn

Research Site, New York

Research Site, Salt Lake City